Additive Effect of Brinzolamide 1%/Brimonidine 0.2% Fixed Dose Combination As Adjunctive Therapy to Travoprost
Phase of Trial: Phase IV
Latest Information Update: 01 May 2016
At a glance
- Drugs Brimonidine/brinzolamide (Primary) ; Travoprost
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Alcon
- 28 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 24 Jan 2014 According to ClinicalTrials.gov record, planned end date changed from 1 Oct 2014 to 1 Mar 2014.
- 24 Jan 2014 According to ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.